Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 12, 2020 - Issue
Submit an article Journal homepage
107
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Advanced Medical Devices for Preparation and Administration of Chemotherapeutic Agents: Results from a Multi-Dimensional Evaluation

Lucrezia Ferrario1 Carlo Cattaneo – LIUC University and LIUC Business School, Castellanza, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8561-898XView further author information
ORCID Icon,
Fabrizio Schettini1 Carlo Cattaneo – LIUC University and LIUC Business School, Castellanza, ItalyView further author information
,
Elisabetta Garagiola1 Carlo Cattaneo – LIUC University and LIUC Business School, Castellanza, ItalyView further author information
,
Adriana Cecchi2 ARCS – Azienda Regionale di Coordinamento per la Salute, Udine, ItalyView further author information
,
Lucia Lugoboni3 Bee Care, Lugano, SwitzerlandView further author information
,
Paolo Serra4 Brotzu Hospital, Cagliari, ItalyView further author information
,
Emanuele Porazzi1 Carlo Cattaneo – LIUC University and LIUC Business School, Castellanza, ItalyView further author information
&
Emanuela Foglia1 Carlo Cattaneo – LIUC University and LIUC Business School, Castellanza, ItalyORCID Iconhttps://orcid.org/0000-0003-1381-9069View further author information
ORCID Icon show all
Pages 711-722 | Published online: 01 Dec 2020

Figures & data

Figure 1 Prisma Flow Chart.

Note: Adapted from Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.Citation28
Figure 1 Prisma Flow Chart.

Table 1 Safety and Efficacy Indicators, Derived from Literature Evidence

Figure 2 Beta distributions for the efficacy indicator.

Figure 2 Beta distributions for the efficacy indicator.

Table 2 Economic Evaluation and Cost-Efficacy Analysis

Figure 3 Gamma distributions for the process cost.

Figure 3 Gamma distributions for the process cost.

Figure 4 Gamma distributions for the process cost, without considering the costs related to human resources.

Figure 4 Gamma distributions for the process cost, without considering the costs related to human resources.

Table 3 Budget Impact Analysis

Table 4 Time Required for the Preparation and the Administration Phases

Figure 5 Gamma distributions for the time spent for the preparation and administration phase.

Figure 5 Gamma distributions for the time spent for the preparation and administration phase.

Table 5 The Definition of System Capacity

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.